heart failure with reduced ejection fraction

Jardiance gets parity with Farxiga in US as FDA clears use in heart failure
Pharmaforum
Wed, 08/18/21 - 11:43 pm
Eli Lilly
Boehringer Ingelheim
FDA
diabetes
Jardiance
heart failure with reduced ejection fraction
Amgen and partners begin second phase 3 trial of omecamtiv mecarbil in patients with heart failure
Pharmaceutical Business Review
Fri, 02/22/19 - 10:04 am
Amgen
heart failure with reduced ejection fraction
Omecamtiv Mecarbil
Cytokinetics
Servier